Cargando…

Aberrant expression of B7-H4 may contribute to the development of hepatocellular carcinoma

In order to determine the effect of B7-H4 on the development of human hepatocellular carcinoma (HCC), the expression levels of B7-H4 were evaluated using reverse transcription-polymerase chain reaction and flow cytometry in HL-7702 and Huh7 cells. B7-H4 protein expression levels were analyzed using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Lingling, Dong, Lijie, Yu, Guohua, Fan, Wanfeng, Zhang, Lin, Wang, Peiyuan, Hu, Xuemei, Zhao, Mingdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355751/ https://www.ncbi.nlm.nih.gov/pubmed/27840912 http://dx.doi.org/10.3892/mmr.2016.5887

Ejemplares similares

Downregulation of B7-H4 suppresses tumor progression of hepatocellular carcinoma
por: Dong, Lijie, et al.
Publicado: (2019)

MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K‐AKT‐β‐catenin pathways
por: Xie, Lulu, et al.
Publicado: (2019)

Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling
por: Dai, Hanhan, et al.
Publicado: (2020)

High expression of B7-H2 or B7-H3 is associated with poor prognosis in hepatocellular carcinoma
por: Zheng, Youshi, et al.
Publicado: (2019)

Contribution of hepatitis B virus X protein-induced aberrant microRNA expression to hepatocellular carcinoma pathogenesis
por: WEI, Zhiyuan, et al.
Publicado: (2019)

Aberrant regulation of Wnt signaling in hepatocellular carcinoma
por: Liu, Li-Juan, et al.
Publicado: (2016)

Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway
por: Xie, Lulu, et al.
Publicado: (2019)

Aberrant FHIT transcripts in hepatocellular carcinomas.
por: Chen, Y. J., et al.
Publicado: (1998)

Aberrant alteration of peripheral B lymphocyte subsets in hepatocellular carcinoma patients
por: Wu, Jiaoxiang, et al.
Publicado: (2023)

Relatively Small Contribution of Methylation and Genomic Copy Number Aberration to the Aberrant Expression of Inflammation-Related Genes in HBV-Related Hepatocellular Carcinoma
por: Yu, Dianke, et al.
Publicado: (2015)

Canonical WNT Signaling Activated by WNT7B Contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by Inhibiting Mitophagy
por: Liu, Li-Juan, et al.
Publicado: (2022)

B7-H4 overexpression is essential for early hepatocellular carcinoma progression and recurrence
por: Kang, Fu-Biao, et al.
Publicado: (2017)

Sinomenine Suppresses Development of Hepatocellular Carcinoma Cells via Inhibiting MARCH1 and AMPK/STAT3 Signaling Pathway
por: Yang, Wei, et al.
Publicado: (2021)

Characterization of a Soluble B7-H3 (sB7-H3) Spliced from the Intron and Analysis of sB7-H3 in the Sera of Patients with Hepatocellular Carcinoma
por: Chen, Weiwei, et al.
Publicado: (2013)

Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma
por: Song, Min-Ae, et al.
Publicado: (2013)

An aberrant DNA methylation signature for predicting hepatocellular carcinoma
por: Zhang, Renhua, et al.
Publicado: (2020)

Precore Mutation of Hepatitis B Virus May Contribute to Hepatocellular Carcinoma Risk: Evidence from an Updated Meta-Analysis
por: Liao, Yun, et al.
Publicado: (2012)

Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide
por: CUI, LIMING, et al.
Publicado: (2016)

Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
por: Chen, Lujun, et al.
Publicado: (2018)

The diagnostic and prognostic significance of small nuclear ribonucleoprotein Sm D1 aberrantly high expression in hepatocellular carcinoma
por: Wang, Huaxiang, et al.
Publicado: (2022)

Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis
por: Dai, Wei, et al.
Publicado: (2022)

Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review)
por: DONG, YOUHONG, et al.
Publicado: (2014)

Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics
por: Li, Zhao, et al.
Publicado: (2017)

Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
por: De Matteis, Serena, et al.
Publicado: (2018)

Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma
por: Krivtsova, Olga, et al.
Publicado: (2018)

Correction to: Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
por: Chen, Lujun, et al.
Publicado: (2018)

Aberrant Akt2 signaling in the RPE may contribute to retinal fibrosis process in diabetic retinopathy
por: Daley, Rachel, et al.
Publicado: (2023)

Low Expression of KAT6B May Affect Prognosis in Hepatocellular Carcinoma
por: Jiang, Junjie, et al.
Publicado: (2021)

Aberrant Expression of BUB1B Contributes to the Progression of Thyroid Carcinoma and Predicts Poor Outcomes for Patients
por: Yan, Hai-chao, et al.
Publicado: (2022)

Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma
por: Cai, Changzhou, et al.
Publicado: (2019)

Clinical significance of aberrant DEUP1 promoter methylation in hepatocellular carcinoma
por: Yu, Qiwen, et al.
Publicado: (2019)

Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma
por: Zhong, Dani, et al.
Publicado: (2017)

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)

Epigenetic aberrations of gene expression in a rat model of hepatocellular carcinoma
por: Boycott, Cayla, et al.
Publicado: (2022)

SMAD7 loci contribute to risk of hepatocellular carcinoma and clinicopathologic development among Chinese Han population
por: Ji, Jiansong, et al.
Publicado: (2016)

A New Approach to Evaluating Aberrant DNA Methylation Profiles in Hepatocellular Carcinoma as Potential Biomarkers
por: Yang, Yuan, et al.
Publicado: (2017)

Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma
por: Zhang, Bei, et al.
Publicado: (2017)

Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture
por: Álvarez, Eva G., et al.
Publicado: (2021)

DJ-1/FGFR-1 Signaling Pathway Contributes to Sorafenib Resistance in Hepatocellular Carcinoma
por: Chen, Xin, et al.
Publicado: (2022)

Integrating the Epigenome and Transcriptome of Hepatocellular Carcinoma to Identify Systematic Enhancer Aberrations and Establish an Aberrant Enhancer-Related Prognostic Signature
por: Huang, Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gvf180kfh0uvr44vejkd4k29jj